Integrative multi-omics Mendelian randomization reveals key lipid metabolism genes as therapeutic targets for diabetic nephropathy pathogenesis

expression was sparse, with no evident disease-associated shifts. These findings indicate discordance between genetically inferred risk effects and observed expression patterns, suggesting complex regulatory mechanisms.